Lung metastasis following temporary discontinuation of lenvatinib and tislelizumab in hepatocellular carcinoma: A case report

doi:10.4240/wjgs.v17.i3.100951

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (33)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series.

Item

Count

PDF

HTML

Figures (1-4)

Sum=33

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=0

Mar 27, 2025 (publication date) through Feb 24, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastrointest Surg. Mar 27, 2025; 17(3): 100951
Published online Mar 27, 2025. doi: 10.4240/wjgs.v17.i3.100951

Full Size Figure Download Figure

Figure 2 Liver Biopsy. The outcome confirmed the diagnosis of hepatocellular carcinoma (poor differentiation) on December 06, 2023. A and B: The microscopic view of the liver biopsy.

Citation: Wang CD, Liu RD, Liu MJ, Song J. Lung metastasis following temporary discontinuation of lenvatinib and tislelizumab in hepatocellular carcinoma: A case report. World J Gastrointest Surg 2025; 17(3): 100951
URL: https://www.wjgnet.com/1948-9366/full/v17/i3/100951.htm
DOI: https://dx.doi.org/10.4240/wjgs.v17.i3.100951